Antibacterial prescription pattern and adverse drug reactions in childhood pneumonia
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20250487Keywords:
Antibacterial drugs, Childhood pneumonia, Prescription patternAbstract
Background: Antibacterial drugs play an important role in the treatment of Pneumonia-a leading cause of death globally among children. To determine the class, dosing schedule, Adverse Drug Reactions (ADRs), selection criteria and World Health Organisation (WHO) prescribing indicators of antibacterials used for pneumonia.
Methods: Following the Institutional Review Board (IRB) clearance, 18 months long descriptive study was conducted among 432 paediatric patients admitted with Pneumonia in a tertiary care center. Details on antibacterial prescription with selection criteria and associated ADRs were collected. Causality, preventability and severity of ADRs were assessed. WHO prescribing indicators were calculated. Data analysed using SPSS software.
Results: Aminopenicillins (61.2%) were the major antibacterial class prescribed and the major antibacterial was Ampicillin (34.6%) with dosage regimen 32-66 mg/kg Intravenously four times daily (34.4%) with mean treatment duration 3.6±1.26 days. Major route of administration was intravenous (57%) and 99% patients received empirical treatment. The ADRs reported were Gentamicin & Ampicillin induced Hypersensitivity reactions and Vancomycin induced Redman Syndrome. WHO prescribing indicators: Average number of antibacterials per encounter 2.42, Antibacterials prescribed by generic name 96.56%, Encounters with injection 98.37%, Antibacterials from Essential Medicines List (EML) 90.9%.
Conclusions: Aminopenicillins were the major antibacterial class, Ampicillin was the major antibacterial, Inj. Ampicillin 32-66 mg/kg intravenously four times daily with mean duration 3.6±1.26 days was the commonest dosage regimen prescribed. Most antibacterials were from EML, prescribed in generic name, selected empirically and administered intravenously. Three ADRs were reported. Prescribing indicators were calculated.
Metrics
References
Pneumonia. 2022. Available at: https://www.who.int/newsroom/fact. Accessed on 12 September 2024.
Ghimire M, Bhattacharya SK, Narain JP. Pneumonia in South-East Asia Region: Public health perspective. Indian J Med Res. 2012;135(4):459–68.
World Health Organization. Revised WHO classification and treatment of pneumonia in children at health facilities: evidence summaries. Available at: https://www.ncbi.nlm.nih.gov. Accessed on 22 September 2024.
Ndu IK, Ekwochi U, Osuorah CDI, Onah KS, Obuoha E, Odetunde OI, et al. Danger signs of childhood pneumonia: caregiver awareness and care seeking behavior in a developing country. Int J Pediatr. 2015;2:167261. DOI: https://doi.org/10.1155/2015/167261
Smith DK, Kuckel DP, Recidoro AM. Community-Acquired Pneumonia in Children: Rapid Evidence Review. 2021;104(6):618–25.
Pandey N, Cascella M. Beta-lactam antibiotics. InStatPearls. 2023 Jun 4. StatPearls Publishing.
Krause KM, Serio AW, Kane TR, Connolly LE. Aminoglycosides: An Overview. Cold Spring Harb Perspect Med. 2016;6(6):27029. DOI: https://doi.org/10.1101/cshperspect.a027029
Batra P, Deo V, Mathur P, Gupta AK. Cotrimoxazole, a wonder drug in the era of multiresistance: Case report and review of literature. J Lab Physicians. 2017;9(3):210–3. DOI: https://doi.org/10.4103/0974-2727.208261
Nguyen PT, Tran HT, Truong HT, Nguyen VT, Graham SM, Marais BJ. Paediatric use of antibiotics in children with community acquired pneumonia: A survey from Da Nang, Vietnam. J Paediatr Child Health. 2019;55(11):1329–34. DOI: https://doi.org/10.1111/jpc.14413
Notification and Report on National List of Essential Medicines. 2022. Available at: https://main.mohfw.gov. Accessed on 12 September 2024.
Moinuddin K, Altaf MA. Study of prescribing pattern of antibiotic in pediatric patients with pneumonia. J Appl Pharm. 2012;4(3):67.
Kafle D. Prescribing pattern of antibiotics in respiratory tract infections in the pediatric indoor patients at Manipal teaching hospital. Nepal J Med Sci. 2022;7(2):46-51.
Baby B, Das S, Haque I, Sherief H. A Study on Prescribing Pattern of Antibiotics for Respiratory Tract Infection in Pediatric Outpatient in A Tertiary Care Hospital: A Prospective Observational Study. Int J of Pharm Sci Review and Res. 2019;21;59:30–3.
Lipsett SC, Hall M, Ambroggio L, Hersh AL, Shah SS, Brogan TV, et al. Antibiotic Choice and Clinical Outcomes in Ambulatory Children with Community-Acquired Pneumonia. J Pediatr. 2021;229:207-15. DOI: https://doi.org/10.1016/j.jpeds.2020.10.005
Karuniawati HI, Yulianti T, Aini DK, Nurwienda FI. Impact of antimicrobial stewardship program on the use of antibiotics in pneumonia patients at teaching hospital in surakarta Indonesia. Int J Appl Pharm. 2021;13(1):20-3. DOI: https://doi.org/10.22159/ijap.2021.v13s1.Y0067
Di Pietro P, Della Casa Alberighi O, Silvestri M, Tosca MA, Ruocco A, Conforti G, et al. Monitoring adherence to guidelines of antibiotic use in pediatric pneumonia: the MAREA study. Ital J Pediatr. 2017;22;43:113. DOI: https://doi.org/10.1186/s13052-017-0432-2
Dean P, Florin TA. Factors Associated With Pneumonia Severity in Children: A Systematic Review. J Pediatric Infect Dis Soc. 2018;7(4):323–34. DOI: https://doi.org/10.1093/jpids/piy046
Kafle D. Prescribing pattern of antibiotics in respiratory tract infections in the pediatric indoor patients at manipal teaching hospital. Nep J Med Sci. 2022;7(2):46–51. DOI: https://doi.org/10.3126/njms.v7i2.47258
Cutts FT, Zaman SMA, Enwere G, Jaffar S, Levine OS, Okoko JB, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005;26(9465):1139–46. DOI: https://doi.org/10.1016/S0140-6736(05)71876-6
Gessner BD, Sutanto A, Linehan M, Djelantik IGG, Fletcher T, Gerudug IK, et al. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Lancet. 2005;365(9453):43–52. DOI: https://doi.org/10.1016/S0140-6736(04)17664-2
Katzung BG, editor. Basic & clinical pharmacology. Fourteenth edition. New York Chicago San Francisco Athens London Madrid Mexico City Milan New Delhi Singapore Sydney Toronto: McGraw-Hill Education. 2018: 1250.
Vilas-Boas AL, Fontoura MS, Xavier-Souza G, Araújo-Neto CA, Andrade SC, Brim RV, et al. PNEUMOPAC-efficacy study group. Comparison of oral amoxicillin given thrice or twice daily to children between 2 and 59 months old with non-severe pneumonia: a randomized controlled trial. J Antimicrobial Chemoth. 2014;69(7):1954-9. DOI: https://doi.org/10.1093/jac/dku070
Caballero J, Rello J. Combination antibiotic therapy for community-acquired pneumonia. Ann Intensive Care. 2011;23:48. DOI: https://doi.org/10.1186/2110-5820-1-48
Ahmed A, Azim A, Gurjar M, Baronia AK. Current concepts in combination antibiotic therapy for critically ill patients. Indian J Crit Care Med. 2014;18(5):310–4. DOI: https://doi.org/10.4103/0972-5229.132495
Rodríguez-Calvillo JA, Lana A, Cueto A, Markham WA, López ML. Psychosocial factors associated with the prescription of generic drugs. Health Policy. 2011;101(2):178–84. DOI: https://doi.org/10.1016/j.healthpol.2010.10.015
WHO Expert Committee on the Use of Essential Drugs - 1998 - The use of essential drugs eight. Available at: https://apps.who.int/iris/bitstream. Accessed on 21 August 2024.
Schrüfer P, Brockow K, Stoevesandt J, Trautmann A. Predominant patterns of β-lactam hypersensitivity in a single German Allergy Center: exanthem induced by aminopenicillins, anaphylaxis by cephalosporins. Allergy Asthma Clin Immunol. 2020;17;16:102. DOI: https://doi.org/10.1186/s13223-020-00488-0
Connolly M, McAdoo J, Bourke JF. Gentamicin-induced anaphylaxis. Ir J Med Sci. 2007;176(4):317–8. DOI: https://doi.org/10.1007/s11845-007-0077-z
Khurana C, de Belder MA. Red-man syndrome after vancomycin: potential crossreactivity with teicoplanin. Postgrad Med J. 1999;75(879):41–3. DOI: https://doi.org/10.1136/pgmj.75.879.41
Downloads
Published
How to Cite
Issue
Section
